IGC Appoints Carrolee Barlow, MD, PhD as Advisor to Help Develop Cannabis Related Products for Treating Various End Points of Parkinson ¢â€ž ¢s Disease and Movement Disorders (PDMD) March 12, 2018 Read More »
IGC Partners with Parkinson ¢â€ž ¢s Institute and Clinical Center to Develop Cannabis Related Products for Treating Various End Points of Parkinson ¢â€ž ¢s Disease and Movement Disorders (PDMD) March 1, 2018 Read More »
IGC Announces Third Quarter Financial Results Advances Hyalolex to Commercialization Stage February 20, 2018 Read More »
IGC ¢â€ž ¢s CEO to Speak at CEO Healthcare Symposium in NY on February 12 & 13 February 12, 2018 Read More »
